Jiraphun Jittikoon

976 total citations
51 papers, 614 citations indexed

About

Jiraphun Jittikoon is a scholar working on Infectious Diseases, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jiraphun Jittikoon has authored 51 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jiraphun Jittikoon's work include Tuberculosis Research and Epidemiology (8 papers), Drug-Induced Adverse Reactions (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Jiraphun Jittikoon is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Drug-Induced Adverse Reactions (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Jiraphun Jittikoon collaborates with scholars based in Thailand, United Kingdom and Philippines. Jiraphun Jittikoon's co-authors include Wanvisa Udomsinprasert, Usa Chaikledkaew, Sittisak Honsawek, Sermsiri Sangroongruangsri, Surakameth Mahasirimongkol, Sukanya Wattanapokayakit, Nuanjun Wichukchinda, Wasun Chantratita, Ammarin Thakkinstian and Abhasnee Sobhonslidsuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Jiraphun Jittikoon

47 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiraphun Jittikoon Thailand 14 151 133 115 88 87 51 614
Anne Paccaly United States 15 242 1.6× 143 1.1× 175 1.5× 55 0.6× 191 2.2× 35 841
Jonathan Q. Tran United States 19 170 1.1× 287 2.2× 169 1.5× 154 1.8× 136 1.6× 43 1.0k
Shixue Dai China 12 176 1.2× 212 1.6× 136 1.2× 34 0.4× 80 0.9× 28 742
Shilpa M. Patel India 12 109 0.7× 246 1.8× 195 1.7× 21 0.2× 68 0.8× 41 718
Julio Dávila Spain 12 75 0.5× 185 1.4× 54 0.5× 216 2.5× 186 2.1× 33 759
Ronald Goldwater United States 12 118 0.8× 136 1.0× 190 1.7× 36 0.4× 37 0.4× 32 708
Rakesh K. Goyal United States 18 50 0.3× 179 1.3× 108 0.9× 35 0.4× 179 2.1× 68 1.0k
Sarah Allegra Italy 16 248 1.6× 131 1.0× 203 1.8× 56 0.6× 119 1.4× 59 801
Zhenwei Yang China 13 201 1.3× 208 1.6× 81 0.7× 22 0.3× 106 1.2× 35 618
H. Dralle Germany 11 63 0.4× 191 1.4× 122 1.1× 95 1.1× 194 2.2× 32 711

Countries citing papers authored by Jiraphun Jittikoon

Since Specialization
Citations

This map shows the geographic impact of Jiraphun Jittikoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiraphun Jittikoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiraphun Jittikoon more than expected).

Fields of papers citing papers by Jiraphun Jittikoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiraphun Jittikoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiraphun Jittikoon. The network helps show where Jiraphun Jittikoon may publish in the future.

Co-authorship network of co-authors of Jiraphun Jittikoon

This figure shows the co-authorship network connecting the top 25 collaborators of Jiraphun Jittikoon. A scholar is included among the top collaborators of Jiraphun Jittikoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiraphun Jittikoon. Jiraphun Jittikoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Praditsitthikorn, Naiyana, Lisa J. White, Aronrag Meeyai, et al.. (2025). Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach. PLoS ONE. 20(3). e0315772–e0315772.
3.
Jittikoon, Jiraphun, Wanvisa Udomsinprasert, Sitaporn Youngkong, et al.. (2025). Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand. ClinicoEconomics and Outcomes Research. Volume 17. 33–43. 1 indexed citations
4.
Wu, Olívia, Jiraphun Jittikoon, Montarat Thavorncharoensap, et al.. (2024). Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand. Scientific Reports. 14(1). 17693–17693. 1 indexed citations
5.
Udomsinprasert, Wanvisa, et al.. (2024). Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis. Bone and Joint Research. 13(6). 261–271. 6 indexed citations
6.
Jittikoon, Jiraphun, et al.. (2024). Protective effect of clusterin against interleukin‐1β‐induced apoptosis and inflammation in human knee osteoarthritis chondrocytes. Clinical and Translational Science. 17(7). e13881–e13881. 6 indexed citations
7.
8.
Udomsinprasert, Wanvisa, et al.. (2023). Effect of galectin-3 on synovial inflammation in knee osteoarthritis via stimulating phosphatidylinositol-3-kinase/Akt pathway. International Immunopharmacology. 122. 110673–110673. 4 indexed citations
9.
Jittikoon, Jiraphun, et al.. (2023). Effect of vitamin D supplementation on circulating level of autophagosome protein LC3A, inflammation, and physical performance in knee osteoarthritis. Clinical and Translational Science. 16(12). 2543–2556. 3 indexed citations
10.
Jittikoon, Jiraphun, et al.. (2023). Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand. PLoS ONE. 18(11). e0291918–e0291918. 1 indexed citations
11.
Jittikoon, Jiraphun, et al.. (2023). Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand. PLoS ONE. 18(4). e0284829–e0284829. 3 indexed citations
12.
13.
Jittikoon, Jiraphun, et al.. (2022). Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand. SHILAP Revista de lepidopterología. 7 indexed citations
14.
Mahasirimongkol, Surakameth, et al.. (2021). HLA-A*24:07 as a Potential Biomarker for Carbamazepine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Filipino Patients. Pharmacogenomics. 22(8). 465–472. 5 indexed citations
15.
Wattanapokayakit, Sukanya, Surakameth Mahasirimongkol, Usa Chaikledkaew, et al.. (2021). CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients. Heliyon. 7(4). e06852–e06852. 3 indexed citations
16.
17.
Jittikoon, Jiraphun, et al.. (2020). Economic impact of medical genetic testing on clinical applications in Thailand. PLoS ONE. 15(12). e0243934–e0243934. 4 indexed citations
18.
Udomsinprasert, Wanvisa, Yong Poovorawan, Voranush Chongsrisawat, et al.. (2019). Leukocyte mitochondrial DNA copy number as a potential biomarker indicating poor outcome in biliary atresia and its association with oxidative DNA damage and telomere length. Mitochondrion. 47. 1–9. 16 indexed citations
19.
Jittikoon, Jiraphun, Surakameth Mahasirimongkol, Angkana Charoenyingwattana, et al.. (2015). Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations. Journal of Human Genetics. 61(2). 119–127. 28 indexed citations
20.
Jittikoon, Jiraphun, et al.. (2013). Synthesis, Topoisomerase I Inhibitory and Cytotoxic Activities of Chromone Derivatives. Medicinal Chemistry. 9(3). 329–339. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Paccaly Breakdown of academic impact, for papers by Jonathan Q. Tran Breakdown of academic impact, for papers by Shixue Dai Breakdown of academic impact, for papers by Shilpa M. Patel Breakdown of academic impact, for papers by Julio Dávila Breakdown of academic impact, for papers by Ronald Goldwater Breakdown of academic impact, for papers by Rakesh K. Goyal Breakdown of academic impact, for papers by Sarah Allegra Breakdown of academic impact, for papers by Zhenwei Yang Breakdown of academic impact, for papers by H. Dralle
Rankless by CCL
2026